| Title {1} | A drug free solution for improving the quality of life of fibromyalgia patients (Fibrepik): study protocol of a multicenter, randomized, controlled effectiveness trial. |
| Trial registration {2a and 2b}. | ClinicalTrials.gov NCT05058092 |
| Protocol version {3} | V3.0 - March 11, 2022 |
| Funding {4} | Sponsor's own funds |
| Author details {5a} |
CHIPON Emilie1, BOSSON Jean-Luc2, MINIER Laure1, DUMOLARD Anne3, VILOTITCH Antoine4, CROUZIER David1, MAINDET Caroline5 1 REMEDEE LABS SA, Montbonnot-Saint Martin, France; 2 TIMC Laboratory CNRS-UMR 5525, Univ. Grenoble Alpes; Public Health Department, CHU Grenoble Alpes, Grenoble, 38000 France; 3 Pain Medicine Department, CHU Grenoble Alpes, Grenoble, 38000 France; 4 Data engineering cell - CHU Grenoble Alpes, Grenoble, 38000 France; 5 Pain Medicine Department, CHU Grenoble Alpes, Grenoble, 38000 France; TIMC Laboratory CNRS-UMR 5525, Univ. Grenoble Alpes. |
| Name and contact information for the trial sponsor {5b} | CHIPON Emilie – emilie.chipon@remedee.com |
| Role of sponsor {5c} | The sponsor participated in the meetings to set up the methodology, but it is not involved in the collection, analysis, and interpretation of data. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.